Comfortan 10 mg Solution is a Health Canada–registered veterinary drug (DIN 02496658) held by Eurovet Animal Health B.v., containing Methadone Hydrochloride. Health Canada lists its status as Marketed (status date 05 Nov 2020). Nexara Health has matched 226 registrations of Methadone Hydrochloride across 16 other regulated markets.

Health Canada registration

Methadone Hydrochloride registered in other markets

226 registrations of the same molecule in 16 national registries outside Canada (first 81 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Methadone Hydrochloride worldwide →

Regulator price references for Methadone Hydrochloride

Published list or reimbursement prices for Methadone Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Comfortan (DIN 02496658) marketed in Canada?

Yes. Health Canada lists DIN 02496658 as Marketed as of 05 Nov 2020.

Who holds the Canadian licence for this product?

Eurovet Animal Health B.v. is the company of record in the Health Canada Drug Product Database.

Is Methadone Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 226 registrations in 16 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02496658, status date 2020-11-05; national medicine registries: BDA, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, Medicines Authority, NEAK PUPHA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA; price sources: DoH SEP database, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, PBS, SFDA, SUKL SCAU. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02496658, status date 2020-11-05; national medicine registries: BDA, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, Medicines Authority, NEAK PUPHA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA; price sources: DoH SEP database, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, PBS, SFDA, SUKL SCAU.

Health Canada Drug Product Database (DPD), DIN 02496658, status date 2020-11-05; national medicine registries: BDA, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, Medicines Authority, NEAK PUPHA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA; price sources: DoH SEP database, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NEAK PUPHA, PBS, SFDA, SUKL SCAU. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.